Does calcitonin modulate anterior pituitary hormone secretion?

Area of Science:

• Endocrinology
• Neuroendocrinology
• Cellular Physiology

Background:

• Calcitonin (CT) is a hormone primarily known for its role in calcium regulation.
• The presence of CT-like immunoreactivity in the pituitary and central nervous system suggests potential neuroendocrine functions.
• Understanding CT's role in pituitary hormone secretion is crucial for neuroendocrine research.

Purpose of the Study:

• To investigate the effect of salmon calcitonin (sCT) on basal and stimulated pituitary hormone secretion in healthy subjects.
• To explore the potential mechanisms underlying CT's influence on pituitary cells.
• To determine if CT acts as a neurotransmitter or paracrine regulator within the neuroendocrine system.

Main Methods:

• Administered sCT infusion to healthy subjects to assess effects on basal luteinizing hormone (LH), follicle-stimulating hormone (FSH), prolactin (PRL), and thyroid-stimulating hormone (TSH) levels.
• Conducted gonadotropin-releasing hormone (GnRH) and thyrotropin-releasing hormone (TRH) stimulation tests during sCT and saline infusions.
• Measured and analyzed hormone levels in serum samples.

Main Results:

• sCT infusion did not significantly alter basal secretory levels of LH, FSH, PRL, and TSH in healthy subjects.
• During GnRH and TRH tests, sCT infusion led to a clear inhibition of TSH-stimulated levels and PRL secretion.
• Gonadotropin secretion (LH and FSH) was not significantly affected by sCT infusion.

Conclusions:

• sCT significantly inhibits TSH and PRL secretion in response to TRH stimulation, but not basal levels or GnRH-stimulated gonadotropins.
• The differential effect on TRH- vs. GnRH-stimulated hormones suggests distinct intracellular calcium-mediated mechanisms or release pathways.
• The widespread CT-like immunoreactivity supports the hypothesis that CT may function as a neurotransmitter or paracrine regulator in the pituitary and CNS.